Altimmune (ALT) EBT Margin Growth (5y) (2015 - 2025)
Altimmune (ALT) EBT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.31 Mn |
| Sep 30, 2025 | -37.97 Mn |
| Jun 30, 2025 | -44.25 Mn |
| Mar 31, 2025 | -40.48 Mn |
| Dec 31, 2024 | -46.29 Mn |
| Sep 30, 2024 | -45.52 Mn |
| Jun 30, 2024 | -49.26 Mn |
| Mar 31, 2024 | -48.78 Mn |
| Dec 31, 2023 | -8.47 Mn |
| Sep 30, 2023 | -558,949.00 |
| Jun 30, 2023 | -28.12 Mn |
| Mar 31, 2023 | -9.60 Mn |
| Dec 31, 2022 | -3.74 Mn |
| Sep 30, 2022 | -118.50 Mn |
| Jun 30, 2022 | -25.15 Mn |
| Mar 31, 2022 | -5.97 Mn |
| Dec 31, 2021 | 10,930.00 |
| Sep 30, 2021 | -2.07 Mn |
| Jun 30, 2021 | -1.78 Mn |
| Mar 31, 2021 | -165,330.00 |